Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Vidacare Corporation
An observational study to determine the safety and effectiveness of Proximal Humerus Intraosseous (IO) vascular access for delivery of contrast medium for Computed Tomography (CT) examination. The hypothesis is that Proximal Humerus IO access in conjunction with a pressure-limited power injection device can be safely and effectively used to deliver contrast medium for CT examination.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Aged 18 years or older
Has received intraosseous (IO) vascular access at the proximal humerus insertion site via EZ-IO 45 mm needle set, as standard of care
Requires Computed Tomography (CT) examination with contrast media delivery via proximal humerus intraosseous catheter, as standard of care
Cognitively and physically able to give written consent to participate in the study or is obtained from a Legally Authorized Representative (LAR)
You may not be if
Fracture in target bone, or significant trauma to the site
Excessive tissue and/or absence of adequate anatomical landmarks in target bone
Infection in target area
IO insertion in past 24 hours, prosthetic limb or joint or other significant orthopedic procedure in target bone
Allergy to contrast media
Imprisoned
Pregnant
Requires English language translation other than Spanish
Has received proximal humerus IO access with an IO catheter other than the EZ-IO 45 millimeter (mm) needle set system
Has existing proximal humerus IO access using the EZ-IO 45 mm needle set but IO catheter is mal-positioned or dislodged
Clareo Health | Observational Study of CT Dye Administration Through the Intraosseous Vascular Access Route
